Among the significantly different expressed genes, we found the 3’-UTR of SIK1 contained potential binding sites for miR-183-5p according to the miRWalk database (Figure 5C), and it was a pivotal result for us as SIK1 has been documented to inhibit tumor progression in both thyroid and breast cancer (16, 17). Here, SIK1 is linked to breast carcinoma.